Professional Documents
Culture Documents
TRANSPLANTE RENAL
Frecuencia
Morbimortalidad - supervivencia
Implicaciones en pediatra
NEFROPATIA TERMINAL
Causas
D.M. (44%) Otras G.N. (23%) E.F.Q. (6%) P.N.Crnica (5%) Otras
Sobrecarga hdrica
Acidemia Disfuncin Orgnica
Alteracion H-E.
Stockall C, et Al. Renal transplantation. In: Sharpe M D, Gelb A W (eds) Anesthesia and transplantation. Boston: Butterworth Heinemann, 1999: 241274
Stockall C, et Al. Renal transplantation. In: Sharpe M D, Gelb A W (eds) Anesthesia and transplantation. Boston: Butterworth Heinemann, 1999: 241274
HIGADO Metabolismo
SISTEMA GASTROINTESTINAL
Current Anaesthesia and Critical Care (1999) 10, 286290
TRANSPLANTE RENAL
CONTRAINDICACIONES
Generales Especificas
Malignidad incurable Edad (?) Infx. Sistmica incurable Otra enfermedad sistmica Obesidad mrbida Abuso OH, tabaco, drogas Inestabilidad emocional Ambiente no solidario
TRANSPLANTE RENAL
CONTRAINDICACIONES
Generales Especificas
TRANSPLANTE RENAL
CONSIDERACIONES PRE ANESTESICAS
Procedimiento programado / semiprogramado Pruebas cruzadas / HLA Dilisis previa
TABLE 1 -- PATHOPHYSIOLOGIC CONSEQUENCES OF CHRONIC RENAL FAILURE IMPORTANT FOR THE ANESTHESIOLOGIST Abnormality Anemia Mechanism of Abnormality/Clinical Presentation Decreased erythropoetin production, diminished erythrocyte survival (normochromic, normocytic anemia), diminished erythrocyte production (fibrosis of the bone marrow) Qualitative dysfunction (normal platelet count, decreased platelet factor III activity, abnormal platelet aggregation), bleeding diathesis Balanced between reduced O2 -carrying capacity (anemia) and improved O2 capacity (shift of oxyhemoglobin dissociation curve to the right) CHF (primary: uremic cardiomyopathy; secondary: fluid overload), CAD (accelerated atherosclerosis), uremic pericarditis, cardiac tamponade, dysrhythmias (hyperkalemia, hypocalcemia)
Platelet dysfunction
TABLE 1 -- PATHOPHYSIOLOGIC CONSEQUENCES OF CHRONIC RENAL FAILURE IMPORTANT FOR THE ANESTHESIOLOGIST
Arterial hypertension
TABLE 1 -- PATHOPHYSIOLOGIC CONSEQUENCES OF CHRONIC RENAL FAILURE IMPORTANT FOR THE ANESTHESIOLOGIST Acidbase abnormalities Gastrointestinal abnormalities Endocrine disturbances Dialysis-related problems Metabolic acidosis Uremic gastroenteritis, nausea and vomiting, peptic ulcer disease, gastrointestinal bleeding Secondary hyperparathyroidism, osteomalacia, renal osteodystrophy (bone pain, fractures) Dialysis dementia, dysequilibrium syndrome after acute dialysis (cerebral edema), hypovolemia (hypotension after anesthetic induction following recent dialysis), peritonitis (peritoneal dialysis), systemic anticoagulation (after dialysis)
TRANSPLANTE RENAL
CONSIDERACIONES PRE ANESTESICAS
Comorbilidad
DM HTA ICC EAC Enf. pulmonar - Malignidad 20 60% Morbilidad < 2% Mortalidad rara Rgos postqx Edios preqx Protocolo autotransfusin Premedicacin
Donantes vivos*
TABLE 2 -- PERIOPERATIVE PROBLEMS IN PATIENTS WITH DIABETES IMPORTANT FOR THE ANESTHESIOLOGIST Abnormality Clinical Relevance Treatment/Precautions
Electrolyte imbalance
Cardiac dysrhythmias
Diffuse Vascular insufficiencies: Surgical or medical atherosclero myocardial infarction, stroke, therapy; close sis peripheral vascular occlusive perioperative surveillance disease, and so forth Systolic arterial hypertension Hyperglyc. Hyperosmolarity, hyperkalemia, dehydration, coma Sweating, tachycardia, hypertension, coma Antihypertensives Frequent determinations of serum glucose; insulin, hydration Frequent determinations of serum glucose; glucose
Hypoglyc.
Ketoacidosis
TRANSPLANTE RENAL
CONSIDERACIONES PRE ANESTESICAS
Regional Tcnica anestsica General
Premedicacin
Monitoreo
TRANSPLANTE RENAL
INDUCCION Posicin de paciente
Prevencin hipotermia
Induccin Rpida? Tiopental Etomidato Propofol Fraccin libre duplicada V1/2 depuracin sin Cambio (TIVA)
TRANSPLANTE RENAL
INDUCCION
Relajante Muscular - v1/2b (hr) Rocuronio 1.2 1.6 Vecuronio 1.3 1.6 Atracurio 0.3 0.4 Cis-atracurio 0.5 0.6 Mivacurio 2 min 2 min
Sch 2 min 2 min
TRANSPLANTE RENAL
INDUCCION
Opioides Fentanyl
Sulfentanyl Alfentanyl
farmacocintica estable
depresion ventilatoria > Fr. Libre y V.D.
TRANSPLANTE RENAL
INDUCCION
Manejo de V.A. Mscara Larngea vs TOT < requerim. Anestsico < rgo infeccin V.R. < rgo atelectasia < cambio hemodinmico
TRANSPLANTE RENAL
MANTENIMIENTO
Halogenados Isofluorane
Desfluorane Halotano Enfluorane Sevofluorane Biotransformacin, Depr. Miocardica, fl. renal Hepatitis (dialisis crnica) > Incidencia rechazo
Compuesto A
N2O?
TRANSPLANTE RENAL
MANTENIMIENTO
Propofol
Droperidol?
Pediatric Surgery International. 17(2-3):175-9, 2001 Mar.
TRANSPLANTE RENAL
FACTORES QUE AFECTAN LA VIABILIDAD RENAL
*Manejo de donante *Preservacin del injerto *Manejo de receptor Vivo Cadver
Hidratacin
TA
TRANSPLANTE RENAL
FACTORES QUE AFECTAN LA VIABILIDAD RENAL PO2>100 *Manejo de donante Vivo Normocapnia Cadver TAS>100 *Preservacin del GU>100 injerto Heparina *Manejo de receptor
TRANSPLANTE RENAL
FACTORES QUE AFECTAN LA VIABILIDAD RENAL
*Manejo de donante *Preservacin del injerto *Manejo de receptor Tiempos isquemia
Caliente Fra
TRANSPLANTE RENAL
FACTORES QUE AFECTAN LA VIABILIDAD RENAL
*Manejo de donante *Preservacin del injerto *Manejo de receptor
*Diuresis temprana
TRANSPLANTE RENAL
FACTORES QUE AFECTAN LA VIABILIDAD RENAL
*Manejo de donante *Preservacin del injerto *Manejo de receptor Oligoanuria
F. mecnicos
F. no mecnicos
TRANSPLANTE RENAL
MANEJO INTRAOPERATORIO Oligo-anuria F. mecnicos Pre-renal
Post-renal
vasculares
F. no mecnicos
TRANSPLANTE RENAL
MANEJO INTRAOPERATORIO Oligo-anuria F. mecnicos Pre-renal
Post-renal obstructiva
F. no mecnicos
TRANSPLANTE RENAL
MANEJO INTRAOPERATORIO Oligo-anuria F. mecnicos
Hipovolemia Hipotensin NTA Rechazo agudo
F. no mecnicos
TRANSPLANTE RENAL
MANEJO INTRAOPERATORIO
Vol. Intravascular Albmina Diurticos Manitol Calcio antagonistas Dopamina dopexamina Coctel renal
Prevencin N.T.A.
TRANSPLANTE RENAL
MANEJO INTRAOPERATORIO
PVC 10-15 TAS > 120 PMAP > 20
TRANSPLANTE RENAL
MANEJO INTRAOPERATORIO Na-K ATPasa
Diurticos Umbral isqumico
Prevencin N.T.A.
Manitol
FUROSEMIDA
Proteccin (temprana?)
Riesgos
TRANSPLANTE RENAL
MANEJO INTRAOPERATORIO Verapamilo Ca-antagonistas I.O. P.O. Dopamina (Discutida proteccin) Prevencin N.T.A. Dopexamina (Beneficio?) Coctel Renal Dx 0.45%+SS 0.45 N Albumina 37.5 g Manitol 37.5 g Furosemida 80 mg
TRANSPLANTE RENAL
MANEJO INTRAOPERATORIO Complicaciones Hipertensin
Hipotensin NTG IECA
Arritmias
Hiperkalemia
TRANSPLANTE RENAL
MANEJO INTRAOPERATORIO Implicaciones
D.M. IAM silente Disautonoma
TRANSPLANTE RENAL
MANEJO POST OPERATORIO
Extubacin: mayora despiertos Reversin RNM Analgesia P.O. MORFINA
Tbosis. A. renal
TRANSPLANTE RENAL
MANEJO POST OPERATORIO
Anuria oliguria P.O. NTA!! Donante cadaver volemia Vasopresor nefrotx. inotrpicos Tiempo preservacin ciclosporina Rechazo ag. Causa QX
TRANSPLANTE RENAL
MANEJO POST OPERATORIO
H.T.A. TAS > 160 mmHg Dolor? Hipoxemia? Volemia?
TRANSPLANTE RENAL
MANEJO DEL DONANTE
VIVO
TRANSPLANTE RENAL
MANEJO DEL DONANTE
VIVO
TRANSPLANTE RENAL
MANEJO DEL DONANTE
VIVO En general sin complicaciones a largo plazo (aun si son donantes de alto riesgo)
Siebels M et al. Nephrol Dial Transplant (2003) 18: 26482654
Tcnica anestsica: acorde a protocolos de cada entidad y tipo de intervencin (nefrectoma laparoscpica vs abierta)
TRANSPLANTE RENAL
MANEJO DEL DONANTE
CADAVERICO
Hipotensn Hipotermia Tr. Colgeno Alt. Metablicas Malignidad Infx. Bacteriana o viral C.I.D. Hs B - HIV
TRANSPLANTE RENAL
MANEJO DEL DONANTE
CADAVERICO
TRANSPLANTE RENAL
MANEJO DEL DONANTE
PO2 >100, normocapnia CADAVERICO Volemia adecuada Manejo intraoperatorio Hto 30% TAS > 100 GU > 100 c/hr Heparina Vasopresores NTA
TRANSPLANTE RENAL
RESULTADOS LARGO PLAZO SOBREVIDA INJERTO 1 AO Donante vivo: HLA identico 95% no idnt. 90% D. cadavrico: primer transpl. 80% retranspl. 70% Muertes: 1% hemorragia cerebral
TABLE 4 -- PERIOPERATIVE PROBLEMS AND ANESTHESIARELATED ADVERSE EVENTS THAT CAN WORSEN SICKLING PROCESS IN PATIENT WITH SICKLE CELL DISEASE Abnormality Presence of hemoglobin S Clinical Relevance Increased tendency for sickling under conditions of reduced oxygen tension (hypoxia) Excessive hemolysis Decreased red cell lifespan Aplastic crises Vaso-occlusive phenomena Painful crises caused by microinfarcts Therapy/Prevention Preoperative exchange transfusion to decrease hemoglobin S concentration to less than 40% Transfusions as needed Avoid sickling conditions (see below) Folic acid supplementation Analgesics
Chronic anemia
Vasoocclusive phenomena
Thromboembolic phenomena (impairment of pulmonary function, increased shunting with reduced PaO2 ), renal microinfarcts (hypostenuria or inability to concentrate urine leads to dehydration, which promotes further sickling and hemolysis) Worsens sickling process
Systemic hypoxia
Worsens sickling process (because of the shift of oxyhemoglobin dissociation curve to the right)
Worsens sickling process
Correct with alkali; maintain adequate circulating volume and adequate ventilation
Maintain normothermia
Hypothermia